This question has been answered by the relevant Government Department.
Question text
Baroness Altmann to ask His Majesty's Government what assessment they have made of the decision by regulatory authorities in the United States of America to disallow further use of the Evusheld monoclonal antibody product; and what steps they will take to ensure appropriate prophylaxis and treatment against COVID-19 for vulnerable immunodeficient and immunocompromised patients. HL5171
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Date Answered
Monday 20 February 2023
Member's Registered Interests
There are no interests to show.
Main Member
Baroness Altmann
Non-affiliated
Life peer